Cite
Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia.
MLA
Iwase, Akira, et al. “Anti-Müllerian Hormone as a Marker of Ovarian Reserve Following Chemotherapy in Patients with Gestational Trophoblastic Neoplasia.” European Journal of Obstetrics & Gynecology & Reproductive Biology, vol. 167, no. 2, Apr. 2013, pp. 194–98. EBSCOhost, https://doi.org/10.1016/j.ejogrb.2012.11.021.
APA
Iwase, A., Sugita, A., Hirokawa, W., Goto, M., Yamamoto, E., Takikawa, S., Nakahara, T., Nakamura, T., Kondo, M., & Kikkawa, F. (2013). Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia. European Journal of Obstetrics & Gynecology & Reproductive Biology, 167(2), 194–198. https://doi.org/10.1016/j.ejogrb.2012.11.021
Chicago
Iwase, Akira, Atsuko Sugita, Wakana Hirokawa, Maki Goto, Eiko Yamamoto, Sachiko Takikawa, Tatsuo Nakahara, Tomoko Nakamura, Mika Kondo, and Fumitaka Kikkawa. 2013. “Anti-Müllerian Hormone as a Marker of Ovarian Reserve Following Chemotherapy in Patients with Gestational Trophoblastic Neoplasia.” European Journal of Obstetrics & Gynecology & Reproductive Biology 167 (2): 194–98. doi:10.1016/j.ejogrb.2012.11.021.